Tag: Aquavit Pharmaceuticals

All

Aquavit Files Investigation of New Drug for New Botulinum Toxin

Aquavit Pharmaceuticals, Inc. has submitted to the U.S. FDA an Investigation of New Drug package for a new botulinum toxin, DTX-021.

All

Sorry, No Posts Found

All

Study Supports Combining Facelift Surgery With Plasma Skin Resurfacing

Case series suggests performing the procedures together may safely address multiple signs of facial aging while reducing the need for separate operations.

SkinHealth Systems Expands FDA-Cleared Indications for SkinStylus Microneedling Device
New Analysis Reveals Leading Causes of Malpractice Claims in Plastic Surgery
Fractional Laser Treatment Reverses Epigenetic Markers of Skin Aging, Study Finds

Tag: Aquavit Pharmaceuticals

All

Aquavit Files Investigation of New Drug for New Botulinum Toxin

All

Sorry, No Posts Found

All

Study Supports Combining Facelift Surgery With Plasma Skin Resurfacing

SkinHealth Systems Expands FDA-Cleared Indications for SkinStylus Microneedling Device

New Analysis Reveals Leading Causes of Malpractice Claims in Plastic Surgery

Fractional Laser Treatment Reverses Epigenetic Markers of Skin Aging, Study Finds

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links